Recombinant CDKN2A/p14ARF Antibody

Tumor suppressor ARF, Alternative reading frame, ARF, Cyclin-dependent kinase inhibitor 2A, p14ARF

CDKN2A

Q8N726

Human

Human

Not tested

A synthesized peptide derived from human CDKN2A/p14ARF

Tumor suppressor ARF; Alternative reading frame; ARF; Cyclin-dependent kinase inhibitor 2A; p14ARF

K01_3W69

Unconjugated

WB

WB

≥85%

Avoid repeated freeze-thaw cycles. Upon receipt, * 1 month when stored at 2 to 8 °C * 12 months when aliquoted and stored at -20 °C or lower

Yes

1:500~1:1000

10mM PBS, pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.

Monoclonal

CDKN2; MLM

CDKN2A/p14ARF

Ferroptosis

Rabbit

Cyclin dependent kinase inhibitor 2A

Succeed

Shipped at ambient temperature or with ice packs.

IgG